Cobalt Platform
Explore regulated AI clinical software startups and scaleups by regulatory profile, clinical evidence maturity, growth stage, geography, and strategic relevance.
Filters
Refine the company universe by geography, segment, maturity, regulatory profile, and score.
Country
Primary Segment
Growth Stage
Regulatory Profile
Cobalt Score
Regulatory Score
Clinical Evidence Score
Financing Status
Operational Status
Ownership Status
Secondary Segment
Search by company name
-
Accexible
General Information
Ownership Status
PrivateDescription
Accexible is a digital health technology provider offering AI-powered speech analysis for early detection and monitoring of mental health conditions and cognitive disorders. It tackles challenges in timely identification and management of depression, mild cognitive impairment and dementia, where current methods may lack sensitivity or efficiency. The solution leverages AI models to analyze speech inputs via a live demo platform to detect disease indicators and enable monitoring. Operating in the AI diagnostics and monitoring domain, Accexible’s tools are intended for healthcare providers, Medicare Advantage plans and nurse care facilities.Country
SpainOperational Status
OperationalPrimary Segment
AI DiagnosticsWebsite
accexible.comLocation
BarcelonaGrowth Stage
Early GrowthSecondary Segment
Voice BiomarkersRegistration No.
B95886198Year Founded
2018Financing Status
–Enterprise Value
$2MRegulatory Profile
MD/IVD CompanyIntelligence Signals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast updated
2026-05-19T19:27:21.000Z -
Acorai
General Information
Ownership Status
PrivateDescription
Acorai is a Swedish health tech startup founded in Helsingborg that develops non-invasive devices for heart failure management. It tackles limited access to intracardiac pressure monitoring in 60–64 million patients, which drives hospitalization and readmission rates. Its handheld Heart Monitor combines proprietary SAVE sensors—vibration, audio, electrical and external pressure—with AI and machine learning to estimate hemodynamic parameters, detect congestion up to 30 days before symptoms and guide therapy. Operating in cardiovascular remote monitoring and AI-driven diagnostics, it serves clinicians and hospitals.Country
SwedenOperational Status
OperationalPrimary Segment
Remote MonitoringWebsite
acorai.comLocation
HelsingborgGrowth Stage
Early GrowthSecondary Segment
CardiologyRegistration No.
428173900Year Founded
2019Financing Status
–Enterprise Value
$31MRegulatory Profile
MD/IVD CompanyIntelligence Signals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast updated
2026-05-19T19:27:27.000Z -
Ada Health
General Information
Ownership Status
PrivateDescription
Ada Health is a Berlin-based digital health company that uses AI to deliver personalized symptom assessment and care navigation. It addresses limited access to timely healthcare and system overload, especially in low- and middle-income countries. The AI-driven symptom checker app collects demographics, history and symptoms via a chatbot, matches them to over 3,600 conditions and 30,000 codes and provides real-time triage recommendations in health records. Operating in AI diagnostics and digital triage, it serves individuals, clinicians and healthcare organizations.Country
GermanyOperational Status
OperationalPrimary Segment
Clinical Decision SupportWebsite
ada.comLocation
BerlinGrowth Stage
Late GrowthSecondary Segment
Clinical Decision SupportRegistration No.
HRB 189710Year Founded
2011Financing Status
–Enterprise Value
$120–180MRegulatory Profile
MD/IVD CompanyIntelligence Signals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast updated
2026-05-19T19:27:09.000Z -
AI4MedImaging
General Information
Ownership Status
PrivateDescription
AI4MedImaging (AI4CMR) is a Portuguese SME founded in 2019 that develops AI-powered software for automated cardiac MRI analysis. It tackles the time-consuming, expertise-dependent manual assessment of CMR scans that limits scalability, access and timely diagnosis. Its AI segments CMR images to quantify ventricular volumes, myocardial mass, ejection fraction and left ventricular wall motion in two minutes, integrating with PACS, EHR and other hospital systems. In the AI diagnostics and medical imaging domain, it serves cardiologists, radiologists and high-volume healthcare providers.Country
PortugalOperational Status
OperationalPrimary Segment
AI DiagnosticsWebsite
ai4cmr.comLocation
BragaGrowth Stage
Early GrowthSecondary Segment
ImagingRegistration No.
515247910Year Founded
2019Financing Status
–Enterprise Value
No informationRegulatory Profile
MD/IVD CompanyIntelligence Signals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast updated
2026-05-19T19:27:56.000Z -
Aiforia Technologies
General Information
Ownership Status
PrivateDescription
Aiforia Technologies is a University of Helsinki spin-off medical software company specializing in cloud-based deep learning AI solutions for digital pathology. It addresses the growing strain on pathologists faced with rising cancer rates, complex histopathology images and remote work challenges. Its Aiforia Platform enables pathologists, medical scientists and researchers to develop and deploy custom AI models for image analysis, with over 1,000 models analyzing more than one million images. It operates in the AI diagnostics and imaging domain.Country
FinlandOperational Status
OperationalPrimary Segment
AI DiagnosticsWebsite
aiforia.comLocation
HelsinkiGrowth Stage
Late GrowthSecondary Segment
ImagingRegistration No.
2534910-2Year Founded
2013Financing Status
–Enterprise Value
$111–166MRegulatory Profile
MD/IVD CompanyIntelligence Signals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast updated
2026-05-19T19:28:00.000Z -
AILIS
General Information
Ownership Status
PrivateDescription
AILIS is a health tech startup offering a non-invasive breast health monitoring device that combines AI-driven analytics, telemedicine, and a mobile app. It tackles the challenge of early cancer detection in dense breast tissue by performing a painless 4–5 minute thermal imaging exam that assesses blood supply. AI algorithms generate risk predictions in 10–15 minutes, with teleconsultations and radiologist review of suspicious findings. Operating in AI diagnostics, remote monitoring and imaging, the solution is designed for women with dense breasts.Country
PolandOperational Status
OperationalPrimary Segment
Women’s HealthWebsite
https://ailiscare.comLocation
KrakowGrowth Stage
Early GrowthSecondary Segment
ImagingRegistration No.
KRS0000605929Year Founded
2016Financing Status
–Enterprise Value
$80MRegulatory Profile
MD/IVD CompanyIntelligence Signals
Standard Membership Required
You must be a Standard member to access this content.
Already a member? Log in hereLast updated
2026-05-19T19:28:00.000Z